Bruker (BRKR) Long-Term Investments (2023 - 2025)
Bruker (BRKR) posted Long-Term Investments of $11.1 million for Q4 2025, up 158.14% on a QoQ basis from $4.3 million in Q4 2024, and up 158.14% year-over-year from $4.3 million in Q4 2024.
Bruker (BRKR) Long-Term Investments (2023 - 2025) Analysis & Trends
Bruker's Long-Term Investments history runs 3 years deep, the most recent figure standing at $11.1 million for Q4 2025.
- Quarterly Long-Term Investments rose 158.14% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (up 158.14% YoY) and the FY2025 annual result came in at $11.1 million, up 158.14% from the prior year.
- Long-Term Investments was $11.1 million for Q4 2025 at Bruker, up from $4.3 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $11.1 million in Q4 2025 and bottomed at $4.3 million in Q4 2024.
- A 3-year average of $7.9 million and a median of $8.3 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments plunged 48.19% — and 2025, when it surged 158.14%.
- Bruker's Long-Term Investments stood at $8.3 million in 2023, then plunged by 48.19% to $4.3 million in 2024, then soared by 158.14% to $11.1 million in 2025.
- Business Quant data shows BRKR's Long-Term Investments at $11.1 million in Q4 2025, $4.3 million in Q4 2024, and $8.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Dec 31, 2023 | 8.30 Mn |